Mereo BioPharma (MREO) Retained Earnings (2017 - 2026)
Mereo BioPharma (MREO) reported Retained Earnings of -$507.5 million for Q1 2026, down 7.52% year-over-year from -$548.8 million in Q1 2025, and down 1.3% quarter-over-quarter from -$501.0 million in Q4 2025.
Mereo BioPharma (MREO) Retained Earnings (2017 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 10 years of Retained Earnings data on file, last reported at -$507.5 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$507.5 million, down 7.52% year-over-year; the trailing twelve-month figure through Mar 2026 was -$507.5 million (down 7.52% YoY), and the FY2025 annual result was -$501.0 million, down 2558.06% from the prior year.
- Retained Earnings declined to -$507.5 million in Q1 2026 per MREO's latest filing, from -$501.0 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$18.3 million in Q2 2024 and troughed at -$507.5 million in Q1 2026.
- A 5-year average of -$381.0 million and a median of -$455.8 million in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings plunged 3993.42% in 2022, then soared 95.51% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$388.4 million in 2022, then slipped by 8.03% to -$419.6 million in 2023, then soared by 95.51% to -$18.8 million in 2024, then tumbled by 2558.06% to -$501.0 million in 2025, then fell by 1.3% to -$507.5 million in 2026.
- Business Quant data shows MREO's Retained Earnings at -$507.5 million in Q1 2026, -$501.0 million in Q4 2025, and -$493.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | -507.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -507.54 Mn |
| Dec 31, 2025 | -501.02 Mn |
| Sep 30, 2025 | -493.67 Mn |
| Jun 30, 2025 | -486.64 Mn |
| Mar 31, 2025 | -472.03 Mn |
| Dec 31, 2024 | -18.85 Mn |
| Sep 30, 2024 | -455.80 Mn |
| Jun 30, 2024 | -18.28 Mn |
| Mar 31, 2024 | -428.60 Mn |
| Dec 31, 2023 | -419.63 Mn |
| Dec 31, 2022 | -388.43 Mn |
| Dec 31, 2021 | 9.98 Mn |
| Dec 31, 2020 | -408.93 Mn |
| Dec 31, 2019 | 23.51 Mn |
| Dec 31, 2018 | 2.05 Mn |
| Dec 31, 2017 | 2.11 Mn |